Antigeno oligosacarido meningococo grupo c, Corynebacterium diphtheriae crm-197 protein

Meningitec Suspension Para Inyeccion en Jeringa Precargada

10 µg + 15 µg suspensión inyectable en jeringa precargadaSpainSuspendedAuthorised 15 Oct 2007

This page is kept for reference and is not offered to search engines.

Packs

Pack	Code	Status
MENINGITEC SUSPENSION PARA INYECCION EN JERINGA PRECARGADA , 10 jeringas precargadas de 0,5 ml (CON AGUJA)	602687
MENINGITEC SUSPENSION PARA INYECCION EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml (CON AGUJA)	659966

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Antigeno oligosacarido meningococo grupo c, Corynebacterium diphtheriae crm-197 protein

Meningitec Suspension Para Inyeccion en Jeringa Precargada

10 µg + 15 µg suspensión inyectable en jeringa precargadaSpainSuspendedAuthorised 15 Oct 2007

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

Packs

Pack	Code	Status
MENINGITEC SUSPENSION PARA INYECCION EN JERINGA PRECARGADA , 10 jeringas precargadas de 0,5 ml (CON AGUJA)	602687
MENINGITEC SUSPENSION PARA INYECCION EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml (CON AGUJA)	659966

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Antigeno oligosacarido meningococo grupo c, Corynebacterium diphtheriae crm-197 protein
Strength: 10 µg + 15 µg
Dosage form: suspensión inyectable en jeringa precargada
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Suspended
Status in the register: Suspendido
Authorised: 15 Oct 2007
Registration: 69333
Marketing authorisation holder: Nuron Biotech B.V.
Procedure: National, MRP or DCP
Supply: Diagnóstico Hospitalario

Antigeno oligosacarido meningococo grupo c + Corynebacterium diphtheriae crm-197 protein · 10 µg + 12,5 A 25,0 µg · suspensión inyectable

SpainWithdrawn